News
Final results from landmark DYNAGITO® trial published in The Lancet Respiratory Medicine
Boehringer Ingelheim announced data from the landmark 52-week DYNAGITO® trial which show that in people with COPD (chronic obstructive pulmonary disease), Spiolto®Respimat® (tiotropium/olodaterol 5/5µg)...
Press Releases
Lokelma approved in the EU for the treatment of adults with hyperkalaemia
AstraZeneca announced that the EC has granted marketing authorisation for Lokelma (formerly ZS-9, sodium zirconium cyclosilicate) for the treatment of adults with hyperkalaemia. ...
Industry Reports
Takeda Statement Regarding Shire plc
Takeda Pharmaceutical Company Limited notes the share price movement with respect to Shire plc. Takeda confirms that it is considering making...
Press Releases
CPhI & P-MEC China 2018: Build lucrative pharma business partnerships in China
Are you looking for new business partners, extendingyour distributor network or sourcing specific products on the Chinese pharma market? We can...
Drug Research
Niche CDMO adds spray drying for highly potent drugs
IDIFARMA has announced new GMP spray drying capabilities which will make it one of the very few contract development and manufacturing organisations (CDMO) to...
Press Releases
BioLIVE to introduce global biopharma country ranking
BioLIVE – the UBM bioprocessing and manufacturing event opening in October (9-11) in Madrid – announces that it is to build on the success...
Clinical Trials
GeNeuro and Servier announce successful 12-month results in neuroprotection for Phase 2b CHANGE-MS Study with GNbAC1 in Multiple Sclerosis
GeNeuro and Servier announced positive results at 12 months from the CHANGE-MS Phase 2b study of GNbAC1, a novel and promising therapeutic approach for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read